BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28575699)

  • 1. A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia.
    Ishdorj G; Kost SEF; Beiggi S; Zang Y; Gibson SB; Johnston JB
    Leuk Res; 2017 Aug; 59():66-74. PubMed ID: 28575699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation- and Dyskeratosis Congenita Cluster-Dependent Fashion.
    Nelson ND; Dodson LM; Escudero L; Sukumar AT; Williams CL; Mihalek I; Baldan A; Baird DM; Bertuch AA
    Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel form of the telomere-associated protein TIN2 localizes to the nuclear matrix.
    Kaminker PG; Kim SH; Desprez PY; Campisi J
    Cell Cycle; 2009 Mar; 8(6):931-9. PubMed ID: 19229133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation.
    Augereau A; T'kint de Roodenbeke C; Simonet T; Bauwens S; Horard B; Callanan M; Leroux D; Jallades L; Salles G; Gilson E; Poncet D
    Blood; 2011 Aug; 118(5):1316-22. PubMed ID: 21355086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.
    Poncet D; Belleville A; t'kint de Roodenbeke C; Roborel de Climens A; Ben Simon E; Merle-Beral H; Callet-Bauchu E; Salles G; Sabatier L; Delic J; Gilson E
    Blood; 2008 Feb; 111(4):2388-91. PubMed ID: 18077792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere status in chronic lymphocytic leukemia with TP53 disruption.
    Guièze R; Pages M; Véronèse L; Combes P; Lemal R; Gay-Bellile M; Chauvet M; Callanan M; Kwiatkowski F; Pereira B; Vago P; Bay JO; Tournilhac O; Tchirkov A
    Oncotarget; 2016 Aug; 7(35):56976-56985. PubMed ID: 27486974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2.
    Houghtaling BR; Cuttonaro L; Chang W; Smith S
    Curr Biol; 2004 Sep; 14(18):1621-31. PubMed ID: 15380063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heregulin, a new interactor of the telosome/shelterin complex in human telomeres.
    Menendez JA; Benboudjema L; Vellon L; Rubio MA; Espinoza I; Campisi J; Lupu R
    Oncotarget; 2015 Nov; 6(37):39408-21. PubMed ID: 26327598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
    Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS
    Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
    Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
    Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
    Ramsay AJ; Quesada V; Foronda M; Conde L; Martínez-Trillos A; Villamor N; Rodríguez D; Kwarciak A; Garabaya C; Gallardo M; López-Guerra M; López-Guillermo A; Puente XS; Blasco MA; Campo E; López-Otín C
    Nat Genet; 2013 May; 45(5):526-30. PubMed ID: 23502782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
    Bellon M; Datta A; Brown M; Pouliquen JF; Couppie P; Kazanji M; Nicot C
    Int J Cancer; 2006 Nov; 119(9):2090-7. PubMed ID: 16786598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.
    Oh BK; Kim YJ; Park C; Park YN
    Am J Pathol; 2005 Jan; 166(1):73-80. PubMed ID: 15632001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mus musculus and Mus spretus homologues of the human telomere-associated protein TIN2.
    Kim SH; Parrinello S; Kim J; Campisi J
    Genomics; 2003 Apr; 81(4):422-32. PubMed ID: 12676566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins.
    Chen Y; Yang Y; van Overbeek M; Donigian JR; Baciu P; de Lange T; Lei M
    Science; 2008 Feb; 319(5866):1092-6. PubMed ID: 18202258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere biology: a new player in the end zone.
    Colgin L; Reddel R
    Curr Biol; 2004 Oct; 14(20):R901-2. PubMed ID: 15498484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A higher-order entity formed by the flexible assembly of RAP1 with TRF2.
    Gaullier G; Miron S; Pisano S; Buisson R; Le Bihan YV; Tellier-Lebègue C; Messaoud W; Roblin P; Guimarães BG; Thai R; Giraud-Panis MJ; Gilson E; Le Du MH
    Nucleic Acids Res; 2016 Feb; 44(4):1962-76. PubMed ID: 26748096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Rap1 modulates TRF2 attraction to telomeric DNA.
    Janoušková E; Nečasová I; Pavloušková J; Zimmermann M; Hluchý M; Marini V; Nováková M; Hofr C
    Nucleic Acids Res; 2015 Mar; 43(5):2691-700. PubMed ID: 25675958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
    BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.